What is an independent GCP audit?

An independent GCP audit checks whether trial activities, documentation, and data meet applicable Good Clinical Practice requirements.

Why should sponsors independently audit CROs and trial sites?

Independent audits give sponsors objective assurance that delegated trial activities are being managed and documented appropriately.

What areas can a GCP audit cover?

A GCP audit can cover source data, protocol compliance, TMF documentation, CRO processes, monitoring, and data management.

Why is TMF completeness important before submission?

A complete TMF helps ensure critical trial documentation is organised, available, and ready for regulatory review.

Can GCP audit findings be remediated without delaying trial timelines?

Yes, early identification and prioritisation can help close findings while keeping key trial milestones on schedule.

GCP Audit Case Study in India

See how PVCON audited 6 trial sites and 2 CROs, closed 22 findings before submission, improved TMF completeness from 80% to 98%, and kept database lock on schedule.

Protecting Trial Integrity in India

How independent GCP oversight helped a global pharmaceutical sponsor strengthen trial assurance across Indian sites and CROs while keeping database lock on schedule.

Results at a glance: 6 sites and 2 CROs independently audited, 22 findings closed before submission, TMF completeness 80% to 98%, database lock on schedule

A Submission Timeline With an Oversight Gap

A global pharmaceutical sponsor was progressing toward submission with clinical activities being conducted across multiple sites and CRO partners in India.

The programme was moving forward, but one important question remained: did the sponsor have sufficient independent assurance over how trial activities, data and documentation were being managed across its external partners?

The concern extended beyond individual compliance gaps. Weaknesses in source data, protocol deviation management, TMF documentation or data-management activities could become significantly harder to address if identified late in the submission cycle.

The sponsor needed stronger GxP audit oversight before those risks could affect submission readiness or the planned database lock.

Independent Assurance Across 6 Sites and 2 CROs

PVCON conducted an independent GCP audit programme covering six clinical trial sites and two CROs.

Audit scope radiating from the sponsor across six trial sites and two CROs, covering source data, protocol deviations, TMF records and data management

The review focused on the areas most closely connected to trial integrity and submission readiness: source data, protocol deviations, TMF records and data management.

Rather than assessing each area in isolation, PVCON examined how trial activities and supporting evidence connected across sites, CROs and sponsor oversight.

This provided a clearer view of where gaps existed, which findings required priority attention and what needed to be resolved before submission.

The findings were then taken through a structured closure process, strengthening the sponsor's broader GCP compliance and oversight without losing sight of the submission timeline.

What the Independent Review Established

Audit Area	What PVCON Reviewed	Outcome
Trial Sites	Source data and protocol compliance	Findings identified and addressed before submission
CRO Oversight	CRO processes and data-management activities	Stronger visibility over delegated trial activities
TMF	Record completeness and supporting documentation	TMF completeness improved from 80% to 98%
Protocol Deviations	Identification, documentation and handling of deviations	Gaps prioritised and included in the closure programme

Five-stage progression from independent audit and prioritised findings through 22 closures and TMF improvement from 80% to 98% to an on-schedule database lock

Closing 22 Findings Before They Reached Submission

By the end of the engagement, all 22 identified findings had been closed before submission.

TMF completeness increased from 80% to 98%, giving the sponsor a significantly stronger documentation position.

Importantly, the additional audit and remediation activity did not disrupt the planned trial timeline. Database lock remained on schedule.

The sponsor moved toward submission with stronger independent assurance over trial conduct, documentation and data readiness across its Indian operations.

Stronger Oversight Without Slowing the Trial

The value of independent GCP oversight is not simply in identifying gaps.

It is in identifying them early enough to act, resolving them with clear evidence, and strengthening trial assurance without creating another operational delay.

For this sponsor, the engagement helped convert an oversight gap into a clearer and more defensible position ahead of submission.

Need independent assurance across your trial sites or CRO partners? Talk to PVCON Consulting about GCP audit support.